PuraMed BioScience® Announces It Has Commenced a Clinical Study of LipiGesic®M for Children
Schofield, Wis., February 7, 2012 – PuraMed BioScience, Inc. (OTC QB: PMBS) announced today that it has recently commenced a clinical study of its unique non –prescription migraine treatment, LipiGesic®M on children and adolescents. Currently there are no prescription migraine medications recommended for those under the age of 18, and PuraMed hopes to attract that [...]



Try LipiGesic-M within 30 days. If you are not satisfied, simply return the unopened boxes for a full refund.